These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33044797)

  • 1. Standardizing a volume benchmark for cerebrospinal fluids for optimal diagnostic accuracy.
    Kim D; Alperstein SA; Siddiqui MT
    Diagn Cytopathol; 2021 Feb; 49(2):258-266. PubMed ID: 33044797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Utility of Cytology and Flow Cytometry of Cerebrospinal Fluid Samples in Clinical Practice.
    Nam AS; Giorgadze T; Tam W; Chadburn A
    Acta Cytol; 2018; 62(2):130-136. PubMed ID: 29510385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoid and myeloid neoplasms involving cerebrospinal fluid: comparison of morphologic examination and immunophenotyping by flow cytometry.
    Roma AA; Garcia A; Avagnina A; Rescia C; Elsner B
    Diagn Cytopathol; 2002 Nov; 27(5):271-5. PubMed ID: 12411991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphologic and Flow Cytometric Analysis of Cerebrospinal Fluid with T-Cell Lymphoma Involvement: A Retrospective Study of Rare Cases.
    Onur I; Crane GM; Maleki Z
    Acta Cytol; 2015; 59(4):325-31. PubMed ID: 26315545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoreticular malignancies in serous effusions: Cytomorphologic, flow cytometric and immunocytochemical analysis.
    Gupta P; Pandey T; Gautam U; Rajwanshi A; Srinivasan R; Gupta N; Rohilla M; Varma N; Dey P
    Diagn Cytopathol; 2021 May; 49(5):647-656. PubMed ID: 33629825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious.
    Schinstine M; Filie AC; Wilson W; Stetler-Stevenson M; Abati A
    Cancer; 2006 Jun; 108(3):157-62. PubMed ID: 16649227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis.
    French CA; Dorfman DM; Shaheen G; Cibas ES
    Diagn Cytopathol; 2000 Dec; 23(6):369-74. PubMed ID: 11074639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results.
    Glantz MJ; Cole BF; Glantz LK; Cobb J; Mills P; Lekos A; Walters BC; Recht LD
    Cancer; 1998 Feb; 82(4):733-9. PubMed ID: 9477107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma.
    Pittman M; Treese S; Chen L; Frater JL; Nguyen TT; Hassan A; Kreisel F
    Arch Pathol Lab Med; 2013 Nov; 137(11):1610-8. PubMed ID: 24168498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
    Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
    Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility and performance of cell blocks in cerebrospinal fluid cytology: Experience at two teaching hospitals.
    Yoon H; Chen CV; Krishnan V; Grochowski J; Iezza G; Vohra P; Balassanian R; Greenland NY
    Cancer Cytopathol; 2024 Oct; 132(10):621-628. PubMed ID: 38812401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry and cytomorphology evaluation of hematologic malignancy in cerebrospinal fluids: comparison with retrospective clinical outcome.
    Cesana C; Klersy C; Scarpati B; Brando B; Faleri M; Bertani G; Gatti A; Volpato E; Barba C; Ferri U; Scampini L; Grillo G; Lando G; Nosari A; Morra E; Cairoli R
    Ann Hematol; 2011 Jul; 90(7):827-35. PubMed ID: 21212952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma.
    Del Principe MI; Buccisano F; Cefalo M; Maurillo L; Di Caprio L; Di Piazza F; Sarlo C; De Angelis G; Irno Consalvo M; Fraboni D; De Santis G; Ditto C; Postorino M; Sconocchia G; Del Poeta G; Amadori S; Venditti A
    Ann Hematol; 2014 Sep; 93(9):1509-13. PubMed ID: 24752416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors.
    Gajjar A; Fouladi M; Walter AW; Thompson SJ; Reardon DA; Merchant TE; Jenkins JJ; Liu A; Boyett JM; Kun LE; Heideman RL
    J Clin Oncol; 1999 Jun; 17(6):1825-8. PubMed ID: 10561221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
    Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
    J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
    Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
    Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher rate of central nervous system involvement by flow cytometry than morphology in acute lymphoblastic leukemia.
    Dass J; Dayama A; Mishra PC; Mahapatra M; Seth T; Tyagi S; Pati HP; Saxena R
    Int J Lab Hematol; 2017 Oct; 39(5):546-551. PubMed ID: 28649769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of cerebrospinal fluid has low diagnostic yield in samples without atypical morphology or prior history of hematologic malignancy.
    Collie AM; Hill BT; Stevens GH; Fenner K; Gazdick E; Hsi ED
    Am J Clin Pathol; 2014 Apr; 141(4):515-21. PubMed ID: 24619752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic characterization of atypical teratoid/rhabdoid tumor in cerebrospinal fluid.
    Huang EC; Guzman MA; De Girolami U; Cibas ES
    Cancer Cytopathol; 2014 Dec; 122(12):903-8. PubMed ID: 25091318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid cytology: an 11-year experience with 5951 specimens.
    Prayson RA; Fischler DF
    Arch Pathol Lab Med; 1998 Jan; 122(1):47-51. PubMed ID: 9448016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.